A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
Clinical trial NCT01275066 · COMPLETED
Trial details
- NCT number
- NCT01275066
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-08-01
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.